EODData

FRA, 26CA: IMMUNITYBIO INC. DL-0001

25 May 2026
LAST:

6.140

CHANGE:
 0.04
OPEN:
6.200
HIGH:
6.200
ASK:
0.000
VOLUME:
7.4K
CHG(%):
0.65
PREV:
6.180
LOW:
6.120
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
25 May 266.2006.2006.1206.1407.4K
22 May 266.5706.6106.1806.1800
21 May 266.8306.8306.3706.5500
20 May 266.7107.3406.7106.9800
19 May 266.8006.8006.4106.64012.4K
18 May 266.9807.1406.8006.860581
15 May 266.9006.9206.7106.820700
14 May 266.8606.9906.8606.9500
13 May 267.0907.0906.8006.9900
12 May 267.0007.0006.7306.9000

PROFILE

Name:IMMUNITYBIO INC. DL-0001
About:ImmunityBio, Inc., a commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeiGene, Ltd. ImmunityBio, Inc. is based in San Diego, California.
Sector:Healthcare
Industry:Biotechnology
Address:3530 John Hopkins Court, San Diego, CA, United States, 92121
Website:https://immunitybio.com
ISIN:US45256X1037
LEI:529900J9XLBR4HFL4B83

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-2.99 
Forward P/E:-2.00 
PEG Ratio:-2.00 
Price to Sales:21.05 
Price to Book:-2.81 
Profit Margin:1.00 
Operating Margin:-1.74 
Return on Assets:-0.37 
Return on Equity:0.85 
Revenue:70.05M 
Shares:945.25M 
Market Cap:5.804B 

TECHNICAL INDICATORS

MA5:6.505.8%
MA10:6.709.1%
MA20:6.576.9%
MA50:6.638.0%
MA100:5.864.7%
MA200:3.9555.6%
RSI14:51.14
WPR14:-100.00 
MTM14:-0.19
ROC14:-0.03 
ATR:0.41 
Week High:7.3419.5%
Week Low:6.120.3%
Month High:7.3419.5%
Month Low:5.7555.6%
Year High:10.3468.3%
Year Low:1.68264.5%